PBK/TOPK Is a Favorable Prognostic Biomarker Correlated with Antitumor Immunity in Colon Cancers

Immune checkpoint inhibitor therapy has proven efficacy in a subset of colon cancer patients featuring a deficient DNA mismatch repair system or a high microsatellite instability profile. However, there is high demand for more effective biomarkers to expand the colon cancer population responding to...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Dong-Hee, Jeong, Yu-Jeong, Won, Ju-Young, Sim, Hye-In, Park, Yoon, Jin, Hyung-Seung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869639/
https://www.ncbi.nlm.nih.gov/pubmed/35203508
http://dx.doi.org/10.3390/biomedicines10020299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869639/
https://www.ncbi.nlm.nih.gov/pubmed/35203508
http://dx.doi.org/10.3390/biomedicines10020299

Ejemplares similares